• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Segment 4 - Biomarkers in Bone Turnover and Immunoglobulin Expression

Article

Dr Chernew leads the conversation to biomarkers in bone turnover and immunoglobulin expression.

Dr Chernew leads the conversation to biomarkers in bone turnover and immunoglobulin expression. Dr Kumar says the use of biomarkers can be very specific to a disease type. He analyzes the use of bone marrow and bone biomarkers for monitoring myeloma bone disease. He says there are both prognostic and predictive biomarkers which suit different purposes. There are also other emerging biomarkers that are being studied and explored.

Related Videos
Wanmei Ou, PhD, vice president of product, data analytics, and AI at Ontada
Glenn Balasky, executive director of the Rocky Mountain Cancer Center.
Corey McEwen, PharmD, MS
dr linda bosserman
dr andrew leitner
Glenn Balasky during a video interview
dr joseph alvarnas
dr joseph alvarnas
Related Content
© 2024 MJH Life Sciences
AJMC®
All rights reserved.